Clinical Trial Update: A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating AGS-1C4D4 in combination with gemcitabine for metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• AGS-1C4D4
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Carcinoma, Pancreatic Ductal, Pancreatic Cancer | Phase 2 | Status: COMPLETED